Pfizer's offer for Protalix below asking price, Calcalist reports

theflyonthewall.com

Pfizer's (PFE) $1B takeover offer for Israeli pharmaceutical company Protalix (PLX) is below the valuation that Protalix is seeking, Israeli newspaper Calcalist reported in a Hebrew article. Meanwhile, Protalix has selected Citigroup (C) to manage the selling process, the publication added.

View Comments